Coordinated Reset Deep Brain Stimulation
Not Applicable
Recruiting
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Device: Novel Programming (nDBS)Device: Conventional Programming (cDBS)
- Registration Number
- NCT03732898
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
The study will explore the viability of an alternative/novel programming strategy in Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).
- Detailed Description
The study will explore the feasibility of utilizing an alternative/novel programming technique in Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
- Subject with PD implanted bilaterally in the STN and receiving DBS therapy for at least 3 months.
- Tolerates > 12 hours OFF medication and, per clinical judgment, be able to perform all study related procedures.
- Able to understand the study requirements and the treatment procedures and must provide written informed consent before any study-specific tests or procedures are performed.
Key
Exclusion Criteria
- Exhibits significant psychiatric problems, including unrelated clinically significant depression as determined by the investigator.
- A female who is pregnant, is breastfeeding, or is of childbearing potential and planning to get pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Novel Deep Brain Stimulation (nDBS) program Novel Programming (nDBS) This arm will include patients receiving stimulation with a novel Deep Brain Stimulation (nDBS) for Parkinson's Disease (PD). Conventional Deep Brain Stimulation (cDBS) program Conventional Programming (cDBS) This arm will include patients receiving stimulation with a conventional Deep Brain Stimulation (cDBS) for Parkinson's Disease (PD).
- Primary Outcome Measures
Name Time Method Improvement in Quality of Life using new programming paradigm: PDQ-39 approximately 4 weeks Change in Parkinson's Disease Questionnaire (PDQ-39) summary index and sub-scores
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
University Berlin, Charite Virchow
🇩🇪Berlin, Germany
Universitaetsklinikum Wuerzburg
🇩🇪Wuerzburg, Germany
University Berlin, Charite Virchow🇩🇪Berlin, GermanyBoston Scientific Clinical Research ManagerContact855-213-9890BSNClinicalTrials@bsci.com